Leading Ophthalmic Photocoagulator End Use Markets Databank

Leading Ophthalmic Photocoagulator End Use Markets Databank

The Ophthalmic Photocoagulator market was valued at $150.2 Million in 2020, and is projected to reach $251.5 Million by 2029 growing at a CAGR of 5.94% from 2021 to 2029. Hospitals segment is expected to be the highest contributor to this market, with $64.9 Million in 2020, and is anticipated to reach $108.4 Million by 2029, registering a CAGR of 5.91%. Ambulatory Surgery Centers segment is anticipated to reach $82.2 Million by 2029 with the highest CAGR of 5.97%. Hospitals and Ambulatory Surgery Centers segments collectively expected to account for about 75.8% share of the Ophthalmic Photocoagulator market in 2020, with the former constituting around 43.2% share. Ambulatory Surgery Centers and Ophthalmology Clinics segments are expected to witness significant growth rates at a CAGR of 5.97% and 5.96% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 56.8% in the overall Ophthalmic Photocoagulator market in 2020, and is anticipated to reach 56.9% by 2029.